SyVento BioTech is an innovative biotech partner offering end-to-end capabilities to develop, formulate and manufacture next -generation mRNA-based products and innovative medicines. With a state-of-the-art facility located in the EU (Poland), the company specializes in liposomal and LNP technology, providing tailored solutions for the encapsulation and delivery of therapeutic molecules, including small molecules, RNA, DNA, and proteins. Leveraging unique know-how and customer-centric flexibility, SyVento BioTech delivers comprehensive services, including preclinical/clinical drug development, RUO/GMP-grade API production, the manufacturing of commercial and clinical batches, and sterile fill & finish — all under one roof.